218 related articles for article (PubMed ID: 27299299)
21. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
[TBL] [Abstract][Full Text] [Related]
22. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
[TBL] [Abstract][Full Text] [Related]
23. Emerging Genetic Therapy for Sickle Cell Disease.
Orkin SH; Bauer DE
Annu Rev Med; 2019 Jan; 70():257-271. PubMed ID: 30355263
[TBL] [Abstract][Full Text] [Related]
24. Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
El Nemer W; Godard A; El Hoss S
Curr Opin Hematol; 2021 May; 28(3):171-176. PubMed ID: 33631786
[TBL] [Abstract][Full Text] [Related]
25. Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.
Hoban MD; Orkin SH; Bauer DE
Blood; 2016 Feb; 127(7):839-48. PubMed ID: 26758916
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges.
Demirci S; Leonard A; Haro-Mora JJ; Uchida N; Tisdale JF
Adv Exp Med Biol; 2019; 1144():37-52. PubMed ID: 30715679
[TBL] [Abstract][Full Text] [Related]
27. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients.
Kim J; Usmani A; De Simone N; Sarode R
Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100
[TBL] [Abstract][Full Text] [Related]
28. Genetic therapies for sickle cell disease.
Esrick EB; Bauer DE
Semin Hematol; 2018 Apr; 55(2):76-86. PubMed ID: 29958563
[TBL] [Abstract][Full Text] [Related]
29. Correction of the sickle cell mutation in embryonic stem cells.
Chang JC; Ye L; Kan YW
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1036-40. PubMed ID: 16407095
[TBL] [Abstract][Full Text] [Related]
30. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
[TBL] [Abstract][Full Text] [Related]
31. Selective advantage of normal erythrocyte production after bone marrow transplantation of alpha-thalassemic mice.
van den Bos C; Kieboom D; van der Sluijs JP; Baert MR; Ploemacher RE; Wagemaker G
Exp Hematol; 1994 May; 22(5):441-6. PubMed ID: 8174674
[TBL] [Abstract][Full Text] [Related]
32. Promise of gene therapy to treat sickle cell disease.
Romero Z; DeWitt M; Walters MC
Expert Opin Biol Ther; 2018 Nov; 18(11):1123-1136. PubMed ID: 30324810
[TBL] [Abstract][Full Text] [Related]
33. Successful correction of murine sickle cell disease with reduced stem cell requirements reinforced by fractionated marrow infusions.
Felfly H; Trudel M
Br J Haematol; 2010 Feb; 148(4):646-58. PubMed ID: 19930185
[TBL] [Abstract][Full Text] [Related]
34. Evidence for ineffective erythropoiesis in severe sickle cell disease.
Wu CJ; Krishnamurti L; Kutok JL; Biernacki M; Rogers S; Zhang W; Antin JH; Ritz J
Blood; 2005 Nov; 106(10):3639-45. PubMed ID: 16091448
[TBL] [Abstract][Full Text] [Related]
35. Stem cell therapy for sickle cell disease: transplantation and gene therapy.
Walters MC
Hematology Am Soc Hematol Educ Program; 2005; ():66-73. PubMed ID: 16304361
[TBL] [Abstract][Full Text] [Related]
36. Gene Therapy for β-Hemoglobinopathies.
Cavazzana M; Antoniani C; Miccio A
Mol Ther; 2017 May; 25(5):1142-1154. PubMed ID: 28377044
[TBL] [Abstract][Full Text] [Related]
37. Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.
Blau CA
Baillieres Clin Haematol; 1998 Mar; 11(1):257-75. PubMed ID: 10872481
[TBL] [Abstract][Full Text] [Related]
38. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
Ye L; Chang JC; Lu R; Kan YW
Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
[TBL] [Abstract][Full Text] [Related]
39. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic stem cells: potential new applications for translational medicine.
Felfly H; Haddad GG
J Stem Cells; 2014; 9(3):163-97. PubMed ID: 25157450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
